BioCentury
ARTICLE | Clinical News

Cytogen regulatory update

March 20, 1995 8:00 AM UTC

Cytogen Corp. (CYTO) The FDA accepted for filing the Princeton, N.J., company's PLA and ELA for ProstaScint, a monoclonal antibody-based imaging agent that detects the presence and extent of prostate...